2017 Annual Meeting | C42 - Cerebrovascular Disease II: Hemorrhagic Stroke

Sunday 04/23/17
01:00 PM - 03:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Philip B. Gorelick, MD, MPH, FAAN
Participants should be able to discuss key diagnostic and management recommendations for IPH and SAH, discuss key scientific guidance recommendations for diagnosis and management of IPH and SAH, and discuss the role of endovascular therapies and recent clinical trial data in diagnosis and management of IPH and SAH.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider
Case-based, Didactic
Event Timeline
01:00 PM - 01:35 PM Speaker Evidence-based Diagnosis and Management of Intraparenchymal Hemorrhage
Venkatesh Aiyagari, MD
01:35 PM - 01:45 PM Q&A Questions and Answers
Venkatesh Aiyagari, MD
01:45 PM - 02:20 PM Speaker Evidence-based Diagnosis and Management of Aneurysmal Subarachnoid Hemorrhage
Sean D. Ruland, MD
02:20 PM - 02:30 PM Q&A Questions and Answers
Sean D. Ruland, MD
02:30 PM - 02:55 PM Speaker Aspirin: Benefits and Bleeding Risks
Philip B. Gorelick, MD, MPH, FAAN
02:55 PM - 03:00 PM Q&A Questions and Answers
Philip B. Gorelick, MD, MPH, FAAN
Faculty Disclosures
Philip B. Gorelick, MD, MPH, FAAN Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.
Venkatesh Aiyagari, MD Dr. Aiyagari has received publishing royalties from a publication relating to health care.
Sean D. Ruland, MD Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms.